Cargando…

Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor

Multiple evanescent white dot syndrome (MEWDS) is an inflammatory condition of the retina that typically presents unilaterally with multiple gray-white spots in the outer retina or retinal pigmented epithelium and granular changes within the fovea. We report a case of new-onset MEWDS in a patient cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutros, Heidi, Okeagu, Chinwenwa, Sharma, Aman, Shaikh, Saad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040745/ https://www.ncbi.nlm.nih.gov/pubmed/33859903 http://dx.doi.org/10.7759/cureus.13853

Ejemplares similares

Contralateral Recurrences of Post-vaccination Multiple Evanescent White Dot Syndrome
por: Ramirez Marquez, Estefania, et al.
Publicado: (2022)

Rare Case of Bilateral and Asymmetrical Multiple Evanescent White Dot Syndrome
por: Muthusamy, Kumutha, et al.
Publicado: (2023)

Retinitis Pigmentosa Associated with Glucose-6-Phosphate Dehydrogenase Deficiency
por: Thiel, Bryan, et al.
Publicado: (2017)

Multiple evanescent white dot syndromes
por: Silva, Ruwan A., et al.
Publicado: (2011)

Fundus Autofluorescence in Multiple Evanescent White Dot Syndrome
por: Penha, Fernando Marcondes, et al.
Publicado: (2011)

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin
por: Sanon, Vani P, et al.
Publicado: (2017)

Topographic patterns of retinal lesions in multiple evanescent white dot syndrome
por: Ong, Ariel Yuhan, et al.
Publicado: (2023)

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin
por: Philippaert, Koenraad, et al.
Publicado: (2021)

Multiple evanescent white dot syndrome associated with retinal vasculitis
por: Takahashi, Akihiro, et al.
Publicado: (2015)

Tozinameran: Multiple evanescent white dot syndrome: case report
Publicado: (2022)

Tozinameran: Multiple evanescent white dots syndrome: case report
Publicado: (2022)

An Elderly Man with Atypical Multiple Evanescent White Dot Syndrome
por: Wang, Liang, et al.
Publicado: (2022)

Peripapillary retinal lesions: Is it multiple evanescent white dot syndrome?
por: Balamurugan, Sivaraman, et al.
Publicado: (2023)

Effects of the sodium‐glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure
por: Kolwelter, Julie, et al.
Publicado: (2021)

Multiple Evanescent White Dot Syndrome after Human Papillomavirus Vaccination
por: Ogino, Ken, et al.
Publicado: (2014)

Retinal ganglion cell analysis in multiple evanescent white dot syndrome
por: Akiyama, Hideo, et al.
Publicado: (2014)

Multimodal imaging features of resolving multiple evanescent white dot syndrome
por: Casalino, Giuseppe, et al.
Publicado: (2017)

Swept-source OCT in patients with multiple evanescent white dot syndrome
por: Pereira, Felipe, et al.
Publicado: (2018)

Resolution of Photoreceptor Layer Damage in Multiple Evanescent White Dot Syndrome
por: Pellegrini, Francesco, et al.
Publicado: (2018)

Multimodal Imaging in an Unusual Cluster of Multiple Evanescent White Dot Syndrome
por: Gal-Or, Orly, et al.
Publicado: (2017)

Multiple evanescent white dot syndrome and panuveitis: a case report
por: Mizuuchi, Kazuomi, et al.
Publicado: (2020)

Ultra-widefield confocal imaging of multiple evanescent white dot syndrome
por: Kadomoto, Shin, et al.
Publicado: (2020)

Multiple evanescent white dot syndrome following COVID-19 vaccines
por: Bouhout, Soumaya, et al.
Publicado: (2023)

Presumed Müller Cell Activation in Multiple Evanescent White Dot Syndrome
por: Cicinelli, Maria Vittoria, et al.
Publicado: (2023)

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients
por: Wang, Dong-Dong, et al.
Publicado: (2022)

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Idiopathic Choroidal Neovascularisation as the Inaugural Sign of Multiple Evanescent White Dot Syndrome
por: Papadia, Marina, et al.
Publicado: (2010)

Multiple evanescent white dot syndrome: Bilateral disease may be silent and asymmetric
por: Finn, Avni P., et al.
Publicado: (2020)

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
por: Ring, Arne, et al.
Publicado: (2013)

Multiple evanescent white dot syndrome following rabies vaccination: a case report
por: Yang, Jia-song, et al.
Publicado: (2018)

Multiple Evanescent White Dot Syndrome Associated with Coronavirus Infection: A Case Report
por: Adzic Zecevic, Antoaneta, et al.
Publicado: (2023)

Profound bilateral post-partum retinal circulation ischemia in two diabetic mothers with pre-eclampsia
por: Khan, Bilal A., et al.
Publicado: (2018)

Ocular Sarcoidosis Limited to Retinal Vascular Ischemia and Neovascularization
por: Dyer, Gawain, et al.
Publicado: (2016)

Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
por: Lee, Kyung Ae, et al.
Publicado: (2018)

Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events
por: Xie, Yan, et al.
Publicado: (2020)

Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling
por: Sokolov, Victor, et al.
Publicado: (2020)

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial( )
por: Doehner, Wolfram, et al.
Publicado: (2022)

A Rare but Life-Threatening Case of Fournier’s Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin
por: Jahir, Tahmina, et al.
Publicado: (2022)

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
por: van der Hoek, Sjoukje, et al.
Publicado: (2023)

Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection
por: Chin-Loy, Katrina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pp44i6lhm4v3q5othpfd31kdfv